tiprankstipranks
Trending News
More News >
Cara Therapeutics (CARA)
NASDAQ:CARA
US Market
Advertisement

Cara Therapeutics (CARA) Ratios

Compare
2,286 Followers

Cara Therapeutics Ratios

CARA's free cash flow for Q1 2025 was $1.00. For the 2025 fiscal year, CARA's free cash flow was decreased by $ and operating cash flow was $-0.79. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
32.48 7.97 7.20 9.84 10.55
Quick Ratio
31.73 7.97 7.10 9.69 10.64
Cash Ratio
28.54 6.99 2.72 0.76 1.71
Solvency Ratio
-0.96 -0.19 -3.48 -4.44 0.43
Operating Cash Flow Ratio
-29.32 -6.41 -3.36 -3.41 -0.30
Short-Term Operating Cash Flow Coverage
0.00 0.00 -41.05 -34.24 -3.43
Net Current Asset Value
$ -8.07M$ -62.90M$ 145.45M$ 153.76M$ 172.91M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.01 0.01 0.01 0.02
Debt-to-Equity Ratio
0.00 >-0.01 0.01 0.02 0.02
Debt-to-Capital Ratio
0.00 >-0.01 0.01 0.02 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 <0.01 0.01
Financial Leverage Ratio
-4.82 -0.44 1.15 1.09 1.09
Debt Service Coverage Ratio
-3.80 0.00 -42.62 -50.11 3.92
Interest Coverage Ratio
-3.30 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
1.00 0.04 0.04 0.07 0.11
Net Debt to EBITDA
0.95 1.31 0.74 0.11 -4.72
Profitability Margins
Gross Profit Margin
78.80%0.00%82.65%93.25%20.74%
EBIT Margin
-477.04%0.00%-204.16%-384.06%5.71%
EBITDA Margin
-475.06%0.00%-200.17%-382.98%4.14%
Operating Profit Margin
-408.16%0.00%-209.08%-386.85%3.99%
Pretax Profit Margin
-600.65%0.00%-204.16%-384.06%5.71%
Net Profit Margin
-595.39%0.00%-199.23%-382.98%6.23%
Continuous Operations Profit Margin
-595.39%0.00%-204.16%-384.06%6.23%
Net Income Per EBT
99.12%100.00%97.59%99.72%108.95%
EBT Per EBIT
147.16%92.94%97.65%99.28%143.34%
Return on Assets (ROA)
-115.74%-64.25%-45.77%-35.70%3.10%
Return on Equity (ROE)
226.60%27.95%-52.53%-38.76%3.38%
Return on Capital Employed (ROCE)
-81.86%-78.69%-55.13%-38.83%2.13%
Return on Invested Capital (ROIC)
-81.15%-78.38%-52.53%-38.13%2.29%
Return on Tangible Assets
-115.74%-65.33%-45.77%-35.70%3.10%
Earnings Yield
-22.05%-37.84%-1.21%-1.19%0.10%
Efficiency Ratios
Receivables Turnover
3.38 0.00 9.40 19.99 65.45
Payables Turnover
37.50 0.00 0.76 0.28 21.88
Inventory Turnover
0.17 0.00 3.05 0.60 -71.05
Fixed Asset Turnover
0.00 0.00 21.18 6.39 26.39
Asset Turnover
0.19 0.00 0.23 0.09 0.50
Working Capital Turnover Ratio
0.20 0.00 0.28 0.14 0.90
Cash Conversion Cycle
2.29K 0.00 -323.92 -696.00 -16.24
Days of Sales Outstanding
107.89 0.00 38.82 18.26 5.58
Days of Inventory Outstanding
2.19K 0.00 119.71 606.92 -5.14
Days of Payables Outstanding
9.73 0.00 482.45 1.32K 16.68
Operating Cycle
2.30K 0.00 158.53 625.18 0.44
Cash Flow Ratios
Operating Cash Flow Per Share
-3.76 -2.25 -1.47 -1.18 -0.12
Free Cash Flow Per Share
-3.78 -2.25 -1.47 -1.19 -0.12
CapEx Per Share
0.02 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.01 1.00 1.00 1.00 1.06
Dividend Paid and CapEx Coverage Ratio
-167.41 0.00 -1.83K -1.54K -15.72
Capital Expenditure Coverage Ratio
-167.41 0.00 -1.83K -1.54K -15.72
Operating Cash Flow Coverage Ratio
0.00 -57.17 -41.05 -16.36 -1.04
Operating Cash Flow to Sales Ratio
-4.64 0.00 -1.88 -2.61 -0.04
Free Cash Flow Yield
-17.29%-45.90%-1.14%-0.81%-0.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.53 -2.64 -82.90 -84.05 1.02K
Price-to-Sales (P/S) Ratio
27.02 0.00 165.16 321.91 63.73
Price-to-Book (P/B) Ratio
-25.32 -0.74 43.55 32.58 34.57
Price-to-Free Cash Flow (P/FCF) Ratio
-5.78 -2.18 -87.78 -123.29 -1.48K
Price-to-Operating Cash Flow Ratio
-5.81 -2.18 -87.83 -123.37 -1.57K
Price-to-Earnings Growth (PEG) Ratio
-0.49 0.17 7.59 0.08 -9.55
Price-to-Fair Value
-25.32 -0.74 43.55 32.58 34.57
Enterprise Value Multiple
-4.74 -1.35 -81.77 -83.94 1.53K
Enterprise Value
170.32M 23.29M 6.85B 7.40B 8.58B
EV to EBITDA
-4.74 -1.35 -81.77 -83.94 1.53K
EV to Sales
22.50 0.00 163.69 321.49 63.53
EV to Free Cash Flow
-4.82 -1.11 -87.00 -123.13 -1.47K
EV to Operating Cash Flow
-4.84 -1.11 -87.04 -123.21 -1.56K
Tangible Book Value Per Share
-0.86 -6.68 2.96 4.49 5.25
Shareholders’ Equity Per Share
-0.86 -6.63 2.96 4.49 5.25
Tax and Other Ratios
Effective Tax Rate
<0.01 0.00 0.02 <0.01 -0.09
Revenue Per Share
0.81 0.00 0.78 0.45 2.85
Net Income Per Share
-4.82 -1.85 -1.55 -1.74 0.18
Tax Burden
0.99 1.00 0.98 1.00 1.09
Interest Burden
1.26 1.00 1.00 1.00 1.00
Research & Development to Revenue
1.47 0.00 2.19 3.59 0.80
SG&A to Revenue
0.61 0.00 0.72 1.28 0.16
Stock-Based Compensation to Revenue
0.19 0.00 0.42 0.90 0.11
Income Quality
0.78 1.21 0.92 0.68 -0.65
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis